Daiichi Sankyo (OTCMKTS:DSNKY) Updates FY 2024 Earnings Guidance

Daiichi Sankyo (OTCMKTS:DSNKY) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.800-0.800 for the period. The company issued revenue guidance of $12.3 billion-$12.3 billion.

Daiichi Sankyo Stock Performance

Shares of DSNKY opened at $32.71 on Thursday. Daiichi Sankyo has a 1-year low of $25.26 and a 1-year high of $42.48. The company’s fifty day simple moving average is $35.52 and its 200 day simple moving average is $35.37.

About Daiichi Sankyo

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.